Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. (2022)
Attributed to:
Bioengineering to combat the tuberculosis pandemic
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2021-217260
PubMed Identifier: 34607905
Publication URI: http://europepmc.org/abstract/MED/34607905
Type: Journal Article/Review
Volume: 77
Parent Publication: Thorax
Issue: 3
ISSN: 0040-6376